Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that interim results from its Phase 2 clinical trial for minimally invasive posterior lumbar spinal fusion showed that its proprietary "off-the-shelf" product NeoFuse (TM) was both safe and effective.
Stockholders of United States adult stem cell company Angioblast Systems Inc. voted unanimously at a special stockholders' meeting held 19 October in favour of becoming a wholly-owned subsidiary of publicly listed global regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY).
Australian regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers.
Following the Demerger of Dart Energy Limited (ASX:DTE) from Arrow Energy Limited (ASX:AOE) (PINK:ARWEF) and the subsequent establishment of Dart as an independent ASX-listed company, the Board has been seeking to build out the executive and management team of Dart.
Australian Market Report of October 6, 2010 includes: Quantum Resources Limited (ASX:QUR) Gardner Range exploration program is underway; Tissue Therapies Limited (ASX:TIS) was granted the third core VitroGro (R) patent in US; International Finance Corporation commits to further investment in Gryphon Minerals Limited (ASX:GRY); Alkane Resources Limited (ASX:ALK) drill results confirm continuity of gold mineralisation in NSW.
Benitec Limited (ASX:BLT) (PINK:BNIKF) is pleased to announce that it has commenced an R&D program to develop an expressed RNAi product for chronic intractable pain associated with diseases such as cancer and HIV.
Benitec Limited (ASX:BLT) (PINK:BNIKF) are pleased to provide this further update on the United States Patent and Trademark Office's (USPTO) Board of Patent Appeals and Interferences decision ("the Decision") reversing all previous rejections in the US 6,573,099 (the '099 Graham patent) appeal.
